Isolation and identification of intact chromogranin A and two N-terminal processing products, vasostatin I and II, from bovine adrenal medulla chromaffin granules by chromatographic and mass spectrometric methodsBAUER, S. H. J; ZHANG, X. Y; LIANG, F et al.Neuropeptides (Edinburgh). 1997, Vol 31, Num 3, pp 273-280, issn 0143-4179Article

Chromogranin A: secretion of processed products from the stimulated retrogradely perfused bovine adrenal glandHELLE, K. B; MARLEY, P. D; ANGELETTI, R. H et al.Journal of neuroendocrinology. 1993, Vol 5, Num 4, pp 413-420, issn 0953-8194Article

Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segmentsAARDAL, S; HELLE, K. B; ELSAYED, S et al.Journal of neuroendocrinology. 1993, Vol 5, Num 4, pp 405-412, issn 0953-8194Article

Regulatory peptides from chromogranin A and secretogranin II: Putative modulators of cells and tissues involved in inflammatory conditionsHELLE, Karen B.Regulatory peptides. 2010, Vol 165, Num 1, pp 45-51, issn 0167-0115, 7 p.Article

The interplay between chromogranin A-derived peptides and cardiac natriuretic peptides in cardioprotection against catecholamine-evoked stressMAZZA, Rosa; IMBROGNO, Sandra; TOTA, Bruno et al.Regulatory peptides. 2010, Vol 165, Num 1, pp 86-94, issn 0167-0115, 9 p.Article

Chromogranin A: a novel factor acting at the cross road between the neuroendocrine and the cardiovascular systemsDI COMITE, Gabriele; MORGANTI, Alberto.Journal of hypertension. 2011, Vol 29, Num 3, pp 409-414, issn 0263-6352, 6 p.Article

Cardioprotection Against Ischemia/Reperfusion Injury and Chromogranin A-Derived PeptidesPENNA, C; TULLIO, F; PERRELLI, M.-G et al.Current medicinal chemistry. 2012, Vol 19, Num 24, pp 4074-4085, issn 0929-8673, 12 p.Conference Paper

Vasostatin-I, a chromogranin A-derived peptide, in non-selected critically ill patients: distribution, kinetics, and prognostic significanceSCHNEIDER, Francis; BACH, Charlotte; LAVIGNE, Thierry et al.Intensive care medicine (Print). 2012, Vol 38, Num 9, pp 1514-1522, issn 0342-4642, 9 p.Article

A role for chromogranin A (4-16), a vasostatin-derived peptide, on human colonic motility. An in vitro studyGHIA, Jean-Eric; CRENNER, Francis; ROHR, Serge et al.Regulatory peptides. 2004, Vol 121, Num 1-3, pp 31-39, issn 0167-0115, 9 p.Article

Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapyLIXIN MA; LIQIONG LUO; HAIQUAN QIAO et al.Journal of hepatology. 2007, Vol 46, Num 1, pp 98-106, issn 0168-8278, 9 p.Article

A gene therapy for cancer based on the angiogenesis inhibitor, vasostatinXIAO, F; WEI, Y; LI, J et al.Gene therapy (Basingstoke). 2002, Vol 9, Num 18, pp 1207-1213, issn 0969-7128Article

Cytoskeleton mediates negative inotropism and lusitropism of chromogranin A-derived peptides (human vasostatin1-78 and rat CgA_1-64) in the rat heartANGELONE, Tommaso; QUINTIERI, Anna Maria; CARMELA CERRA, Maria et al.Regulatory peptides. 2010, Vol 165, Num 1, pp 78-85, issn 0167-0115, 8 p.Article

Gene transfer of vasostatin, a calreticulin fragment, into neuroendocrine tumor cells results in enhanced malignant behaviorMINGHUI LIU; IMAM, Hassan; ÖBERG, Kjell et al.Neuroendocrinology (Basel). 2005, Vol 82, Num 1, pp 1-10, issn 0028-3835, 10 p.Article

Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colonAMATO, Antonella; CORTI, Angelo; SERIO, Rosa et al.Regulatory peptides. 2005, Vol 130, Num 1-2, pp 42-47, issn 0167-0115, 6 p.Article

Vasostatin I (CgA_17-76) vasoconstricts rat splanchnic vascular bed but does not affect central cardiovascular functionRAHMAN, Ahmed A; SHAHID, Israt Z; FONG, Angelina Y et al.Autonomic neuroscience : basic & clinical. 2012, Vol 166, Num 1-2, pp 22-28, issn 1566-0702, 7 p.Article

Endothelium Dependent Cardiovascular Effects of the Chromogranin A-Derived Peptides Vasostatin-1 and CatestatinFORNERO, S; BASSINO, E; GALLO, M. P et al.Current medicinal chemistry. 2012, Vol 19, Num 24, pp 4059-4067, issn 0929-8673, 9 p.Conference Paper

Relaxation induced by N-terminal fragments of chromogranin A in mouse gastric preparationsAMATO, Antonella; SERIO, Rosa; MULE, Flavia et al.Regulatory peptides. 2007, Vol 139, Num 1-3, pp 90-95, issn 0167-0115, 6 p.Article

Vasostatins, N-terminal products of chromogranin A, are released from the stimulated calf spleen in vitroLIANG, F; DILLEN, L; ZHANG, X. Y et al.Acta physiologica scandinavica. 1995, Vol 155, Num 1, pp 23-30, issn 0001-6772Article

Human recombinant chromogranin A-derived vasostatin-1 mimics preconditioning via an adenosine/nitric oxide signaling mechanismCAPPELLO, Sandra; ANGELONE, Tommaso; TOTA, Bruno et al.American journal of physiology. Heart and circulatory physiology. 2007, Vol 62, Num 1, issn 0363-6135, H719-H727Article

Crucial role of cytoskeleton reorganization in the negative inotropic effect of chromogranin A-derived peptides in eel and frog heartsMAZZA, Rosa; MANNARINO, Cinzia; IMBROGNO, Sandra et al.Regulatory peptides. 2007, Vol 138, Num 2-3, pp 145-151, issn 0167-0115, 7 p.Article

Study of the enzymatic degradation of vasostatin I and II and their precursor chromogranin a by dipeptidyl peptidase IV using high-performance liquid chromatography/electrospray mass spectrometryZHANG, X. Y; DE MEESTER, I; LAMBEIR, A.-M et al.Journal of mass spectrometry. 1999, Vol 34, Num 4, pp 255-263, issn 1076-5174Article

Reduced serum levels of vasostatin-2, an anti-inflammatory peptide derived from chromogranin A, are associated with the presence and severity of coronary artery disease : Genetic and protein markers of CVDLIN LU; YA NAN WANG; QIANG ZHAO et al.European heart journal. 2012, Vol 33, Num 18, pp 2297-2306, issn 0195-668X, 10 p.Article

IMPLICATION DES CHROMOGRANINES A ET B DANS L'IMMUNITE INNEE ACTIVITE ANTIFONGIQUE DE LA VASOSTATINE-I : DECOUVERTE ET DEVELOPPEMENTS = IMPLICATION OF CHROMOGRANINS A AND B IN INNATE IMMUNITY ANTIFUNGAL ACTIVITY OF VASOSTATIN-I : DISCOVERY AND DEVELOPMENTSLugardon, Karine; Metz Boutigue, Marie-Helene.2000, 227 p.Thesis

Immunostaining for vasostatin I distinguishes between ileal and lung carcinoidsCUNNINGHAM, R. T; POGUE, K. M; CURRY, W. J et al.Journal of pathology. 1999, Vol 187, Num 3, pp 321-325, issn 0022-3417Article

Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growthPIKE, S. E; LEI YAO; WIRTH, P et al.Blood. 1999, Vol 94, Num 7, pp 2461-2468, issn 0006-4971Article